Position in GH
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$9,476,644
+$7,790,926 QoQ
Shares Held
63,165
+282.7% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#162
of 594 holders
Holding Since
Dec 2020
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Quadrature Capital Ltd holds $68,972,151 across 20 Diagnostics & Research names. GH ranks #2 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
79,969 | $21,707,585 | |
| 2 | GH |
Guardant Health, Inc.
This page
|
63,165 | $9,476,644 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
6,137 | $7,840,078 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
15,383 | $7,712,420 | |
| 5 | RVTY |
Revvity, Inc.
|
48,540 | $5,400,560 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
7,697 | $4,076,254 | |
| 7 | TWST |
Twist Bioscience Corp
|
33,930 | $3,490,718 | |
| 8 | ICLR |
Icon PLC
|
13,531 | $2,350,470 |
All Filings in GH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,476,644 | 63,165 | Shares | Other | 2026-08-07 | |
| 2025-12-31 | $1,685,718 | 16,504 | Shares | Other | 2026-02-17 | |
| 2025-03-31 | $1,705,065 | 40,025 | Shares | Other | 2025-05-13 | |
| 2022-06-30 | $1,275,591 | 31,621 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $871,474 | 8,713 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,496,119 | 11,968 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $532,661 | 4,133 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||